Elixir Clinical Research is based in Shanghai, China. It has raised $52M in total funding. Latest round: Series A1.
Elixir Clinical Research is based in Shanghai, China. Elixir Clinical Research has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A1 announced in January 2024. The round record for Elixir Clinical Research runs through 2024; nothing later has been disclosed. Investors on record include LYFE Capital, Sinovation Ventures, Chow Tai Fook. 3 distinct backers are named across the disclosed rounds.
Round data for Elixir Clinical Research is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026